Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Carls

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lakartidningen|January 15, 1975
[Cardiotocography in obstetrics]P Belfrage, H Carls, N Raabe
Lakartidningen|January 9, 1974
[Methoxyflurane (Penthrane) or nitrous oxide as agents of analgesia in childbirth?]P Belfrage, H Carls, N Raabe
AIDS (London, England)|July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study GroupJ K Rockstroh, F Bergmann, W Wiesel, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
Mutagenesis|June 22, 1999
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agentsB J Glassner, G Weeda, J M Allan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lakartidningen|January 15, 1975
[Cardiotocography in obstetrics]P Belfrage, H Carls, N Raabe
Lakartidningen|January 9, 1974
[Methoxyflurane (Penthrane) or nitrous oxide as agents of analgesia in childbirth?]P Belfrage, H Carls, N Raabe
AIDS (London, England)|July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study GroupJ K Rockstroh, F Bergmann, W Wiesel, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
Mutagenesis|June 22, 1999
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agentsB J Glassner, G Weeda, J M Allan, et al.
Pageof 1